Clinical Trials

NCT03622788 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
16 participants

Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2019-08-08
Completion:
2027-12-01
Conditions
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Aplastic Anemia
  • Bone Marrow Failure
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Follicular Lymphoma
  • Hodgkin Lymphoma
  • Mantle Cell Lymphoma
  • Myelodysplastic Syndrome
  • Myeloproliferative Neoplasm
  • Non-Hodgkin Lymphoma
  • Plasma Cell Myeloma
Interventions
  • RADIATION
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
No Results Yet
NCT03514108 | COMPLETED | PHASE4
1100 participants

DANHEART (H-HeFT and Met-HeFT)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2018-03-01
Completion:
2025-12-31
Conditions
  • Heart Failure
  • Diabetes
Interventions
  • DRUG
No Results Yet
NCT03494075 | RECRUITING
2000 participants

MyPaTH Story Booth

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-11
Start Date:
2016-03-31
Completion:
2030-06-30
Conditions
  • Narrative Medicine
No Results Yet
NCT03438526 | RECRUITING | PHASE4
190 participants

The Basel BOMP-AID Randomized Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2022-01-03
Completion:
2027-12-31
Conditions
  • Hypoactive Delirium
Interventions
  • DRUG
No Results Yet
NCT03375307 | ACTIVE_NOT_RECRUITING | PHASE2
60 participants

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2020-11-03
Completion:
2026-12-16
Conditions
  • Advanced Bladder Carcinoma
  • Advanced Genitourinary System Carcinoma
  • Metastatic Bladder Carcinoma
  • Metastatic Genitourinary System Carcinoma
  • Stage III Bladder Cancer AJCC v8
  • Stage IV Bladder Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT03321643 | ACTIVE_NOT_RECRUITING | PHASE1
24 participants

Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2018-09-18
Completion:
2027-06-30
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Transformed Non-Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Transformed Non-Hodgkin Lymphoma
  • Richter Syndrome
  • Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT03144895 | COMPLETED | NA
288 participants

Arterial Catheterization by Ultrasound

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2017-03-29
Completion:
2025-04-15
Conditions
  • Ultrasound Therapy; Complications
  • Intensive Care Unit
Interventions
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page